Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process

José G B Derraik, William A Anderson, Elisabeth A Connelly, Yvonne C Anderson
doi: https://doi.org/10.1101/2020.04.02.20051409

ABSTRACT

In the COVID-19 pandemic caused by SARS-CoV-2, hospitals are stretched beyond capacity. There are widespread reports of dwindling supplies of personal protective equipment (PPE), which are paramount to protect frontline medical/nursing staff and to minimize further spread of the virus. We carried out a rapid review to summarize the existing evidence on SARS-CoV-2 survivorship and methods to disinfect PPE gear, particularly N95 filtering facepiece respirators (FFR). In the absence of data on SARS-CoV-2, we focused on the sister virus SARS-CoV-1. We propose a two-step disinfection process, which is conservative in the absence of robust evidence on SARS-CoV-2. This disinfection protocol is based on an initial storage of PPE for ≥4 days, followed by ultraviolet light (UVC), dry heat treatment, or chemical disinfection. Importantly, each of the two steps is based on independent disinfection mechanisms, so that our proposed protocol is a multiplicative system, maximising the efficacy of our disinfection process. This method could be rapidly implemented in other healthcare settings, while testing of each method is undertaken, increasing the frontline supply of PPE, and avoiding many of the upstream issues of supply chain disruption currently being faced.

1. INTRODUCTION

In pandemic situations, such as the current COVID-19 scenario, hospital resources are frequently stretched beyond capacity, as has already occurred in many countries across the globe1. Preventing the spread of COVID-19 to and from health care workers and patients relies on the availability and effective use of personal protective equipment (PPE)1. PPE includes masks, eye protection, gloves, gowns, and in the event of aerosol-generating procedures, N95 filtering facepiece respirators (FFR) or FFP2 standard (or equivalent)2.

Two small studies from the same group in Singapore failed to detect SARS-CoV-2 contamination from PPE, but only on the surface of uncovered shoes3,4. In the case of SARS-CoV-2, it has been estimated that 3.2% of patients in China required intubation5. Evidence from the SARS-CoV-1 epidemic show that doctors and nurses involved in the early critical care period and endotracheal intubation of patients were more than 13 times more likely to acquire SARS-CoV-1 infection themselves6. Given this results in a significant loss of highly specialised healthcare workers in an already strained workforce, avoidance of cross contamination is critical in all health care settings.

The World Health Organization acknowledges the current global stockpile is insufficient, particularly for masks and respirators2, and supply of gowns and goggles is also expected to be insufficient. Coordinating the supply chain of PPE in the midst of an epidemic with many closed borders and reduced freight is challenging. Individual behaviour becomes a factor when people are scared or ill-informed7, theft of PPE can occur, and local supply chain issues mean that inappropriate use of PPE happens due to lack of supply, despite best-practice guidance on its use2. A call for ideas on conserving PPE was made through JAMA on 20 March 20208. One recommendation was reusing PPE. Given the ability of this to rapidly increase supply issues close to the frontline avoiding many of the upstream disruption to the supply chain, this rapid evidence summary was prepared, aiming in particular at the re-utilization of the usually disposable N95 FFRs during the current epidemic. A whole-of-PPE solution has been developed within this protocol, which would be able to be rapidly set up in many healthcare settings.

2. VIRUS SURVIVORSHIP

In light of the very recent identification of SARS-CoV-2, there is a near complete lack of data on the survival of this virus in the environment under different conditions, as well as efficacy of disinfection methods. In the absence of data on SARS-CoV-2, we have focused on SARS-CoV-1, which forms a sister clade virus from the same species9.

2.1. SARS-CoV-1

  • Materials tested included cardboard10, wood11, plastic11-14, fabric11,12, paper11,12, and metal10,11 (Table 1).

  • Survival on a range of materials varied somewhat, and even within type (e.g. stainless steel vs copper10).

  • One study demonstrated survival of 2 days on a disposable polypropylene gown and 24 hours on a cotton gown12 (Table 1).

  • Survival at room temperature and at 40 to 50% relative humidity was as long as 9 days on a polystyrene petri dish13 and approximately 21 days also on plastic14 (Table 1).

  • 9-day survival in respiratory specimens at room temperature12, but more than 14 days in dechlorinated tap water at 4°C and >17 days in urine at 20°C15 (Table 1).

  • Of note, a study with a surrogate coronavirus (i.e. transmissible gastroenteritis virus) showed that this virus was detectable on N95 respirators for up to 24 hours16.

  • It is important to highlight the effect of inoculum size on SARS-CoV-1 inactivation, as clearly shown by Lai et al. 200512. While inoculation of a cotton gown at 104 TCID50/ml led to inactivation in 5 minutes, at 106 TCID50/ml inactivation took 24 hours.

2.2. SARS-CoV-2

  • Only one study found10. Virus undetectable after 4 days on plastic and stainless steel, with shorter survival on cardboard and copper10 (2 days and 4 hours, respectively) (Table 1).

2.3. Survivorship summary

  • It would be ill-advised to rely on a single study on SARS-CoV-2 to draw any clear conclusions on the virus’ survival on different surfaces, especially in light of the existing data on SARS-CoV-1. Thus, until new evidence comes to light, it should be assumed that SARS-CoV-2 may survive for much longer periods under certain conditions, as shown to be the case for SARS-CoV-1.

  • Unless PPE needs to be immediately re-used, PPE that is visually intact and visually clean could be stored for a stand-down period of at least 4 days before undergoing a given disinfection treatment (i.e. ensuring the virus receives a double-hit).

3. DISINFECTION

A wide variety of disinfection methods for PPE have been examined and reported in the literature. These can be characterized as either 1) energetic methods (e.g. ultraviolet, dry and wet heat, and microwave generated steam), or 2) chemical methods (e.g. alcohol, ethylene oxide, bleach, and vapourized hydrogen peroxide). Some of these rapidly and significantly affect N95 filter performance (alcohol17), and others require chemical supplies and specialized facilities (e.g. ethylene oxide, vapourized hydrogen peroxide), or are not readily scalable to large numbers of PPE (e.g. microwave generated steam). We focus here on methods that may be easier to implement at a useful scale.

View this table:
TABLE 1. Studies reporting on the survival of SARS-CoV-1 and SARS-CoV-2.

3.1. Ultraviolet germicidal irradiation (UVGI)

Across the ultraviolet (UV) light spectrum, there are three classifications: UVA (320-400 nm), UVB (280-320 nm), and UVC (200-280 nm)18. UVC light has much stronger germicidal properties than both UVA and UVB19,20. UVC is strongly absorbed by RNA and DNA bases leading to molecular structural damage via a photodimerization process. This results in virus inactivation, such that they are no longer able to replicate20,21. Thus, the focus of this protocol has been on UVC.

  • Studies were found only for SARS-CoV-1 (Table 2). It should be noted that those studies were almost invariably performed on aqueous solutions, in air, or on solid surfaces, i.e. environments that do not directly reflect for example, the micro-environment of N95 FFRs. As a result, the reported applied doses are at best a relative guidance.

  • Ultraviolet light C (UVC) applied doses varied markedly from 300 to 14,500 mJ/cm2, with mixed outcomes (Table 2).

  • At 360 mJ/cm2, SARS-CoV-1 had the highest UV D90 (i.e. required applied dose for 90% inactivation) among nearly 130 viruses from hundreds of published studies summarized by Kowalski22. In addition, in protein medium, an applied dose of 14,500 mJ/cm2 did not completely inactivate the virus18 (Table 2), due to competitive absorption of UV photons by the protein.

  • UVC is effective against SARS-CoV-1, but efficacy of the applied dose (a function of irradiance and time) appears to be highly dependent on many factors, such as inoculum size, culture medium, and shape and type of material12,20,23,24, likely explaining the highly inconsistent findings in the published literature.

  • Based on the available evidence it seems that the effect of relative humidity on UVGI efficacy can be considered negligible22.

  • Importantly, the applied dose is not necessarily the same as the actual dose the treated virus receives. While the applied dose is easy to measure experimentally, the received dose is not. If there are shadowing or absorption effects from the surrounding medium, the actual dose reaching the virus will be lower.

  • The penetration of UV across the multiple layers of an N95 FFR may vary from one model and manufacturer to another25. There is some limited evidence that the majority (approximately 90%) of captured aerosols occurs on the outer filter layer on an N95 FFR26. Therefore, providing a larger UV dose on the outside surface may be desirable.

  • Overall, the effective applied dose is unclear, but appears to be high in comparison to other viruses.

  • Mills et al. (2018) reported on a more extensive set of tests on N95 masks using H1N1 viruses, and included the effects of soiling agents (artificial saliva and/or skin oil) that could reduce the efficacy of UV exposure27. Fifteen different N95 models were tested from a variety of manufacturers, and both the facemask and straps were monitored. All FFRs were disinfected to a level of at least 3 log (i.e. 99.9%), even in the presence of soiling agents, when the UV dose was 1,000 mJ/cm2. Similarly, Heimbuch & Harnish (2019) showed complete disinfection of SARS-CoV-1 from FFR coupons in the presence of artificial saliva (mucin) and artificial skin oil (sebum)23.

  • We estimate that the minimum applied UVC dose for effective deactivation of SARS-CoV-2 on N95 FFRs would likely be close to 1,000 mJ/cm2, particularly in light of the mask’s porous surface (as compared to a smooth surface material), as shown by Heimbuch & Harnish’s 2019 study23.

  • Note that the studies showing SARS-CoV-1 survival at higher doses were most likely confounded by the aqueous media (often with added protein), which would absorb UVC photons, reducing the actual dose reaching the virus.

3.2. Heat treatment

Heat treatment is one of the most common methods for virus deactivation. Heat induces structural changes in virus proteins, disrupting the specific structures necessary to recognize and bind to host cells28.

View this table:
TABLE 2. Studies reporting on the efficacy of ultraviolet (UV) light or heat treatment against SARS-CoV-1.

  • Studies found only for SARS-CoV-1 (Table 2). It should be noted that it is not easy to extrapolate the results from most heat treatment studies reported here. They were often performed with the virus exposed while in solutions, which are mechanistically different from surface contamination, as one would most likely encounter on PPE that is not heavily soiled, particularly N95 FFRs.

  • Environments with lower temperatures seem to be more favourable for virus survival and increased transmission rates14,29,30. While the efficacy of heat treatment appears to be affected by relative humidity14, this relationship for SARS-CoV-1 is unclear, as almost all reported experimental studies failed to report on relative humidity (Table 2). However, the association between temperature and relative humidity was not monotonic for other coronaviruses, with virus survival lowest at moderate relatively humidity (50%)30.

  • Two studies reduced SARS-CoV-1 to below levels of detection with exposure to 56°C at 20 min18 and 60 min31, but one study showed that at 56°C for 30 min heat treatment was ineffective13 in protein medium (Table 2).

  • Heat treatment at 60°C for 30 minutes inactivated SARS-CoV-1 in two studies13,18, irrespective of protein concentrations. However, in Duan et al. (2003)11 the virus was only inactivated at 67°C after 60 minutes, while in Darnell et al.19 inactivation occurred only after 90 minutes at 65°C (Table 2).

  • Overall, heat treatment at 60°C for 90 minutes would reduce SARS-CoV-1 to below levels of detection according to all five heat-treatment studies reported in Table 2.

3.3. Disinfection summary

  • The applied UVC dose should be at least 1,000 mJ/cm2, but we recommend an initial conservative dose of 2,000 mJ/cm2 [applied to each side of N95 FFRs, i.e. wearer-facing and outer sides] to account for possible errors in applied dose estimation, effects of different materials, the challenge to reach the inner filtering layers of FFRs25, as well as the uncertainty regarding the actual susceptibility of SARS-CoV-2 to UVGI.

  • We also recommend heat treatment at 60°C for 90 minutes to treat PPE. This is most likely a very conservative protocol when applied to surface contamination, but in the absence of more precise data, we recommend erring on the side of caution. The 90-minute period of exposure is advisable to ensure there is adequate heat transfer to the inner layers of the FFRs, particularly if a number of masks are being treated at the same time (in which case we would caution against stacking them).

  • While we cannot recommend a target relative humidity due to the paucity of data for SARS-CoV-1, moderate levels are likely to be more desirable (i.e. 40% to 50%).

  • We advise against attempts to disinfect and reuse soiled PPE, as studies using both UVGI and heat treatment show a protective effect of protein and aqueous substrata on SARS-CoV-1 survival.

  • Unpublished experimental data from our group showed that there is minimal UVC radiation on the wearer-facing side of N95 FFRs when the outer side is irradiated (outer 7.34 mW/cm2 vs inner 0.10 mW/cm2). There are reports of widespread SARS-CoV-2 infection among frontline medical staff32, thus, it has to be assumed that SARS-CoV-2 contamination of N95 FFRs would likely occur on both sides, particularly when there is strong evidence of asymptomatic transmission33-35. Therefore, we strongly recommend that both wearer-facing and outer sides of N95 masks be equally treated at the recommended UVC dose.

4. IMPACT OF DISINFECTION ON N95 FFRs

4.1. UVGI

  • Table 3 summarizes six studies that have looked at the effects of UVGI disinfection on the performance and structure of N95 FFRs.

  • In five studies, applied doses varied somewhat from 180 mJ/cm2 to 6,900 mJ/cm2, but there were no observed effects on the N95 FFRs filter aerosol penetration, filter airflow resistance, fit, odour detection, comfort, donning difficulty, or physical appearance (Table 3).

  • Heimbuch & Harnish 201923 evaluated the effects of multiple UVGI cycles on 15 different N95 FFR models. Up to 20 UVGI cycles (total applied UVC dose 20,000 mJ/cm2) did not have a meaningful effect on fit, airflow resistance, or particle penetration for any model. Strap strength was unaffected by 10 UVGI cycles (total applied dose 10,000 mJ/cm2), but 20 cycles had some effect on certain models.

  • Lindsley et al.36 went further, estimating the cumulative effect of extremely high exposures of N95 FFRs to UVC in order to mimic repeated cycles of UVGI treatment. Their lowest applied dose of 120,000 mJ/cm2 reduced the bursting strength of the four N95 models tested by 11% to 42% (depending on the model and the individual layer), with very minor effects on filter aerosol penetration and filter airflow resistance (Table 3). An applied dose of 590,000 mJ/cm2 reduced the breaking strength of straps from the four N95 FFR models tested by 10% to 21%36. It should be noted that their lowest dose is 120,000 mJ/cm2, which is 60 times higher than the conservative minimum dose of 2,000 mJ/cm2 we recommend for SARS-CoV-2 inactivation.

4.2. Heat treatment

  • Table 4 describes five studies that examined the effects of heat treatment on the performance and structure of N95 FFRs.

  • Two studies looked at dry heat treatment at 80°C17,37, reporting no meaningful effects on filter particle penetration and leading to no obvious signs of damage (Table 4).

  • Three studies looked at moist heat incubation at 60°C and 80% relative humidity, two for 15 minutes38,39 and one for 30 minutes40 (Table 4) – there were no meaningful effects on filter aerosol penetration or filter airflow; most FFRs were undamaged, but in the three studies there was separation of the inner foam nose cushion from the FFR body in one particular model.

  • While two studies have looked at the effects of 3 heat treatment cycles for 15 minutes38 and 30 minutes40 at 60°C on N95 FFRs, no peer-reviewed studies seem to have looked at the potential effects of more than 3 heat treatment cycles or multiple cycles of longer duration on N95 FFRs. The exception is Liao et al. (2020)41, who have recently reported that 20 cycles of dry heat at 75°C for 30 minutes did not affect the filtration efficacy of the key fabric in N95 FFRs. However, due to their methodology it was not possible to ascertain whether the fit of the masks for example, would be affected by their treatment protocol.

  • It is worth noting that N95 FFRs are mostly made of polypropylene42, whose maximum operating temperature is approximately 80°C43, so that heat treatment approaching this temperature is probably ill-advised.

4.3. Summary on the impact of disinfection on N95 FFRs

  • We recommend the use of UVGI at a conservative applied UVC dose 2,000 mJ/cm2 (for each surface) for N95 FFRs.

  • Based on the available evidence, there are uncertainties about using our recommended heat treatment at 60°C for 90 minutes for N95 FFRs, as the extended time required for heat treatment may have adverse effects that could compromise its safety for re-use, especially after multiple disinfection cycles. However, a recent report by Liao et al.41 suggests that our proposed heat treatment regimen could be applied to N95 FFRs, and could therefore be adopted in the absence of UVC treatment.

5. DISINFECTION OF OTHER PPE

  • Apart from N95 FFRs, in a pandemic situation the supply of other PPE will be seriously affected, including isolation gowns, surgical masks, face shields, and goggles.

  • Heat treatment (at 60°C for 90 minutes) is recommended for isolation gowns (due to their size and folds) and surgical masks (due to their folded construction).

  • Face shields are made of thin plastic, and usually have a foam-like material on the area that is in direct contact with the face, which would be difficult to clean with chemical disinfectants. As the shields may be damaged at 60°C we therefore recommend that these are treated with UVGI. However, repeated UVGI treatment could affect the clarity of the shields leading to ‘fogging’, in which case they should be discarded.

  • Goggles and other eyewear should be immersed for at least 10 minutes in a chlorine solution at a conservative dose of 5,000 mg/l, which would account for the gradual reduction in chlorine concentration throughout the day. Alternatively, these could be cleaned with an alcohol solution at ≥80%, which should be left for at least 30 seconds44. Afterwards, the goggles/eyewear should be rinsed thoroughly with warm water to remove the disinfectant solution, which could otherwise damage the equipment or cause skin irritation on the wearer. Also, as goggles and other eyewear can be made of different materials, we recommend testing to make sure the disinfectant would not damage them (e.g. ‘fogging’ the lenses) before implementing a chemical disinfection procedure.

6. CAUTIONARY NOTES

6.1. Reuse of N95 FFRs

  • Re-use of FFRs is not encouraged if at all possible, as high levels of disinfection cannot be guaranteed for all FFRs under all circumstances.

  • According to the US Centers for Disease Control and Protection (CDC), it is not possible to determine a maximum possible generic number of safe re-uses for N95 FFRs45.

  • CDC recommend that in the absence of manufacturer’s guidance, N95 FFRs should not be re-used more than 5 times45, as suggested by Fisher & Shaffer 201442 and Bergman et al. 201246 based on the subsequent reduction of FFRs fit.

6.2. Extended use of N95 FFRs

  • According Fisher & Shaffer 201442 extended use is preferable over limited re-use due to a lower risk of contamination with lesser contact with FFR surface.

  • However, extended used leads to an increase in non-compliant behaviours (e.g. adjusting or touching the N95) over time47, increasing the risk of self-contamination.

  • 97% of 542 first-line healthcare workers in China during the COVID-19 response had some form of skin damage, which increased with longer wear of N95 FFRs48. An accompanying editorial highlighted that this increases the likelihood of non-compliant FFR-wearing behaviour, and consequently an increased risk of viral transmission49.

  • As prolonged skin breakdown increases health care workers susceptibility to infection and improper PPE use, access to virtual dermatology clinics for healthcare workers is strongly recommended to manage and treat skin breakdown in health professionals wearing PPE for extended periods.

6.3. Alcohol

  • Due to the widespread use of alcohol-base disinfectants, it is important to emphasise that masks and respirators should not be sprayed with alcohol. Alcohol can remove the electrostatic charge from the respirator filter material, severely reducing the filter’s effectiveness at collecting particles, as shown by a number of studies17.

7. RECOMMENDATIONS

Given the dearth of evidence of PPE disinfection in SARS-CoV-2, our recommendations have been conservative, and have concluded a double-hit process would be favourable to one, until robust evidence on the efficacy of individual methods against SARS-CoV-2 is available. Importantly, each of the two steps is based on two different and independent disinfection mechanisms. Therefore, our dual-step disinfection protocol is a multiplicative process, where if each step can achieve a 3-log reduction, the two consecutive steps would theoretically achieve a 6-log reduction in SARS-CoV-2 (i.e. 99.9999%).

View this table:
TABLE 3. Studies reporting on the effects of ultraviolet germicidal irradiation (UVGI) on N95 filtering facepiece respirators.
View this table:
TABLE 4. Studies reporting on the effects of heat treatment on N95 filtering facepiece respirators.

Given this lack of evidence, clinicians have applied a WIWI (would-I-wear-it) test to the process for developing protocol recommendations. Further, based on the literature that was examined during the preparation of this manuscript, the proposed methodology would most likely achieve disinfection against other pathogenic organisms.

As previously mentioned, PPE that are obviously soiled with organic matter should not be reused, as their disinfection is more difficult to achieve using procedures that would not damage them.

Based on the available evidence, the following disinfection steps are proposed, as outlined in Figure 1.

Figure 1.
Figure 1.

Proposed steps for disinfection from SARS-CoV-2 and re-use of PPE. Dotted lines represent the path (i.e. biohazard waste) for PPE with any sign of damage.

At point of doffing PPE, wearer is to remove and inspect items, looking for any damage or soiling (e.g. blood-stains or presence of organic material). If the PPE is damaged or visibly contaminated, this is to be placed in a bin for biohazard waste. If not damaged or contaminated, PPE is to go into a separate clearly marked bin for re-use. This PPE to be bagged and transported in bin to storage area, where the process outlined below will begin.

1. Inspection and sorting

further careful inspection of PPE (including straps); any soiled and damaged PPE to be discarded, intact PPE to be stored.

2. Storage

All intact PPE to be stored for at least 4 days in a specially designated area (if conditions can be determined, we suggest ∼20°C and 40–50% relative humidity), ensuring no direct contact between items, and minimizing any creases in material. Locally this will be rooms or enclosures where gowns and other PPE can be hung in four rotating enclosures/rooms, and left for four days.

3a. UVGI

After completion of the mandatory stand-down storage period, N95 FFRs and plastic face shields to be treated in the designated UVGI chamber at an applied dose of 2,000 mJ/cm2, with this dose applied to each side, i.e. wearer-facing and outer sides.

3b. Heat treatment

After completion of the mandatory stand-down storage period, polypropylene gowns and surgical masks to undergo heat treatment at 60°C for 90 minutes, possibly at moderate relative humidity (40–50%).

3c. Chemical disinfection

After completion of the mandatory stand-down storage period, eyewear must be disinfected with the appropriate high-grade agent, either through soaking or use of appropriate wipes.

4. Re-inspection and sorting

After UVGI, heat treatment, or chemical disinfection, careful re-inspection of PPE (including straps) must take place; any PPE with any sign of damage must be discarded; intact PPE to be packaged for re-use, after being appropriately marked as PPE derived from disinfection, including the number of the disinfection cycle.

5. Fit test

Frontline staff to ensure that any decontaminated PPE fit properly as new; at any sign of suboptimal fit, decontaminated gear to be immediately discarded.

Afterwards, a new disinfection cycle to begin.

It should be noted that N95 FFRs should probably be discarded after the fifth re-use. An exception to this rule would be under extreme circumstances, where the alternative to further re-use of suboptimal PPE would be not wearing any protection at all.

8. CONCLUSIONS

This protocol provides recommendations for a pragmatic disinfection process for all PPE, that could be rapidly implemented, based on best available evidence. A double-hit process has been proposed due to the immediate urgency of the issue in the current pandemic. Testing of this protocol is in planning stages, but its conservative double-hit approach would most likely achieve disinfection. Based on a total estimated 10% loss of N95 FFRs over 5 cycles, this procedure would increase supply by 400%. We are currently finalizing the tests of the prototype of a UV chamber that would be able to treat a batch of N95 FFRs at the required does in less than 4 minutes.

Careful design of heat chambers and UVC cabinets for re-use of PPE will not only address the problem of short-term supply in the frontline during the pandemic, but also likely lead to considerable cost-savings in the long term. Further, it would also improve the environmental footprint of a given healthcare facility allowing for long-term reuse of PPE, as according to estimates from US hospitals for example, 5.17 tons of waste are generated per staffed bed every year50. It is intended that results of protocol testing will be made available as soon as feasible. It is the right of every healthcare worker responding to the current pandemic to have PPE available not only for their protection, but also to reduce the spread of COVID-1951.

Acknowledgements

We are grateful to Dr William Lindsley (US CDC) for providing very helpful information during the preparation of this manuscript. Thanks to Dr Lesley Voss (Infectious Diseases, Starship Children’s Health), Dr Emma Best (Department of Paediatrics, University of Auckland), and Professor Cameron Grant (Department of Paediatrics, University of Auckland) for their critical review of initial protocol. Also to Sean McNulty and Kevin Mole (UV Solutionz), Geoff Ray (Engineering Works Supervisor, Taranaki District Health Board), and Anthony Valvoi (Sterile Services Coordinator, Taranaki District Health Board) for their assistance with the site design and UVC testing.

Data Availability

There are no relevant data in this study that could be made available.

Funding

JGBD acknowledges the support of an innovation grant from Taranaki Savings Bank Charitable Trust, rediverting efforts to the COVID-19 response. JGBD and YCA acknowledge the support of Tamariki Pakari Child Health and Wellbeing Trust.

Conflicts of interest

The authors have no conflicts of interest to disclose. The funders had no role in study design, manuscript writing, or decision to publish it.

REFERENCES

  1. 1.↵
    Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. 2020: [epub ahead of print].
  2. 2.↵
    World Health Organization. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance, 27 February 2020. World Health Organization; 2020.
  3. 3.↵
    Ong SWX, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) from a symptomatic patient. JAMA. 2020:[epub ahead of print].
  4. 4.↵
    Ong SWX, Tan YK, Sutjipto S, et al. Absence of contamination of personal protective equipment (PPE) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2). Infect Control Hosp Epidemiol. 2020:[epub ahead of print].
  5. 5.↵
    Meng L, Qiu H, Wan L, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology. 2020:[epub ahead of print].
  6. 6.↵
    Fowler RA, Guest CB, Lapinsky SE, et al. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med. 2004;169(11):1198–1202.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Murdoch D, Addidle M, Andersson HS, et al. Politicians: please work together to minimise the spread of COVID-19. N Z Med J. 2020;133(1511):7–8.
    OpenUrlPubMed
  8. 8.↵
    Bauchner H, Fontanarosa PB, Livingston EH. Conserving supply of personal protective equipment – a call for ideas. JAMA. 2020: [epub ahead of print].
  9. 9.↵
    Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544.
    OpenUrl
  10. 10.↵
    van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020:[epub ahead of print].
  11. 11.↵
    Duan SM, Zhao XS, Wen RF, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16(3):246–255.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    Lai MY, Cheng PK, Lim WW. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005;41(7):e67–71.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194(1-2):1–6.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Chan KH, Peiris JS, Lam SY, Poon LL, Yuen KY, Seto WH. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol. 2011;2011:734690.
  15. 15.↵
    Wang XW, Li JS, Jin M, et al. Study on the resistance of severe acute respiratory syndrome-associated coronavirus. J Virol Methods. 2005;126(1-2):171–177.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Casanova L, Rutala WA, Weber DJ, Sobsey MD. Coronavirus survival on healthcare personal protective equipment. Infect Control Hosp Epidemiol. 2010;31(5):560–561.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Viscusi DJ, King WP, Shaffer RE. Effect of decontamination on the filtration efficiency of two filtering facepiece respirator models. J Int Soc Respir Protect. 2007;24:93–107.
    OpenUrl
  18. 18.↵
    Darnell ME, Taylor DR. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion. 2006;46(10):1770–1777.
    OpenUrl
  19. 19.↵
    Darnell MER, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121(1):85–91.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Lindblad M, Tano E, Lindahl C, Huss F. Ultraviolet-C decontamination of a hospital room: amount of UV light needed. Burns. 2019:[epub ahead of print].
  21. 21.↵
    Lytle CD, Sagripanti JL. Predicted inactivation of viruses of relevance to biodefense by solar radiation. J Virol. 2005;79(22):14244–14252.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Kowalski WJ. Ultraviolet germicidal irradiation handbook UVGI for air and surface disinfection. Heidelberg, New York: Springer-Verlag; 2009.
  23. 23.↵
    Heimbuch B, Harnish D. Research to Mitigate a Shortage of Respiratory Protection Devices During Public Health Emergencies. Panama City, Florida: Applied Research Associates; 2019.
  24. 24.↵
    Lambert RJ. Susceptibility testing: inoculum size dependency of inhibition using the Colworth MIC technique. J Appl Microbiol. 2000;89(2):275–279.
    OpenUrlCrossRefPubMed
  25. 25.↵
    Fisher EM, Shaffer RE. A method to determine the available UV-C dose for the decontamination of filtering facepiece respirators. J Appl Microbiol. 2011;110(1):287–295.
    OpenUrlPubMed
  26. 26.↵
    Yi L, Fengzhi L, Qingyong Z. Numerical simulation of virus diffusion in facemask during breathing cycles. Int J Heat Mass Transfer. 2005;48(19):4229–4242.
    OpenUrl
  27. 27.↵
    Mills D, Harnish DA, Lawrence C, Sandoval-Powers M, Heimbuch BK. Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators. Am J Infect Control. 2018;46(7):e49–e55.
    OpenUrlCrossRef
  28. 28.↵
    Wigginton KR, Pecson BM, Sigstam T, Bosshard F, Kohn T. Virus inactivation mechanisms: impact of disinfectants on virus function and structural integrity. Environ Sci Technol. 2012;46(21):12069–12078.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    Marr LC, Tang JW, Mullekom JV, Lakdawala SS. Mechanistic insights into the effect of humidity on airborne influenza virus survival, transmission and incidence. J Roy Soc Interface 2019;16(150):20180298.
    OpenUrl
  30. 30.↵
    Casanova LM, Jeon S, Rutala WA, Weber DJ, Sobsey MD. Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol. 2010;76(9):2712–2717.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212(Suppl 1):119–123.
    OpenUrlCrossRef
  32. 32.↵
    Minder R, Peltier E. Virus knocks thousands of health workers out of action in europe. The New York Times; 24 March 2020.
  33. 33.↵
    Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. Serial interval of COVID-19 among publicly reported confirmed cases. Emerg Infect Dis. 2020;26:[epub ahead of print].
  34. 34.
    Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). 2020:[epub ahead of print].
  35. 35.↵
    Qian G, Yang N, Ma AHY, et al. A COVID-19 Transmission within a family cluster by presymptomatic infectors in China. Clin Infect Dis. 2020:[epub ahead of print].
  36. 36.↵
    Lindsley WG, Martin SB, Thewlis RE, et al. Effects of ultraviolet germicidal irradiation (UVGI) on N95 respirator filtration performance and structural integrity. J Occup Environ Hyg. 2015;12(8):509–517.
    OpenUrlCrossRefPubMed
  37. 37.↵
    Viscusi DJ, Bergman MS, Eimer BC, Shaffer RE. Evaluation of five decontamination methods for filtering facepiece respirators. Ann Occup Hyg. 2009;53(8):815–827.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    Bergman MS, Viscusi DJ, Palmiero AJ, Powell JB, Shaffer RE. Impact of three cycles of decontamination treatments on filtering facepiece respirator fit. J Int Soc Respir Protect. 2011;28(1):48–59.
    OpenUrl
  39. 39.↵
    Viscusi DJ, Bergman MS, Novak DA, et al. Impact of three biological decontamination methods on filtering facepiece respirator fit, odor, comfort, and donning ease. J Occup Environ Hyg. 2011;8(7):426–436.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    Bergman MS, Viscusi DJ, Heimbuch BK, Wander JD, Sambol AR, Shaffer RE. Evaluation of multiple (3-cycle) decontamination processing for filtering facepiece respirators. J Engineered Fibers Fabrics. 2010;5(4):33–41.
    OpenUrl
  41. 41.↵
    Liao L, Xiao W, Yu X, et al. Can N95 facial masks be used after disinfection? And for how many times? Stanford, California, USA: Stanford University; 2020.
  42. 42.↵
    Fisher EM, Shaffer RE. Considerations for recommending extended use and limited reuse of filtering facepiece respirators in health care settings. J Occup Environ Hyg. 2014;11(8):D115–128.
    OpenUrlCrossRefPubMed
  43. 43.↵
    Hindle C. Polypropylene (PP). 2020; https://www.bpf.co.uk/plastipedia/polymers/pp.aspx. Accessed 31 March 2020.
  44. 44.↵
    Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005;61(2):107–111.
    OpenUrlCrossRefPubMed
  45. 45.↵
    National Institute for Occupational Safety and Health. Pandemic planning - recommended guidance for extended use and limited reuse of N95 filtering facepiece respirators in healthcare settings. 2018; https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html. Accessed 26 March 2020.
  46. 46.↵
    Bergman MS, Viscusi DJ, Zhuang Z, Palmiero AJ, Powell JB, Shaffer RE. Impact of multiple consecutive donnings on filtering facepiece respirator fit. Am J Infect Control. 2012;40(4):375–380.
    OpenUrlPubMed
  47. 47.↵
    Rebmann T, Carrico R, Wang J. Physiologic and other effects and compliance with long-term respirator use among medical intensive care unit nurses. Am J Infect Control. 2013;41(12):1218–1223.
    OpenUrlCrossRefPubMed
  48. 48.↵
    Lan J, Song Z, Miao X, et al. Skin damage among healthcare workers managing coronavirus disease-2019. J Am Acad Dermatol. 2020:[epub ahead of print].
  49. 49.↵
    Kantor J. Behavioral considerations and impact on personal protective equipment (PPE) use: Early lessons from the coronavirus (COVID-19) outbreak. J Am Acad Dermatol. 2020; [epub ahead of print].
  50. 50.↵
    Practice Greenhealth. 2016 Sustainability Benchmark Report - A Practice Greenhealth Member Benefit. Reston, VA, USA; 2016.
  51. 51.↵
    World Health Organization. Coronavirus disease (COVID- 19) outbreak: rights,roles and responsibilities of healthworkers, including key considerations for occupational safety and health. Geneva; 2020.
  52. 52.
    Ansaldi F, Banfi F, Morelli P, et al. SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation. J Prev Med Hyg. 2004;45(1-2):5-8.
    OpenUrl
  53. 53.
    Lore MB, Heimbuch BK, Brown TL, Wander JD, Hinrichs SH. Effectiveness of three decontamination treatments against influenza virus applied to filtering facepiece respirators. Ann Occup Hyg. 2012;56(1):92–101.
    OpenUrlCrossRefPubMed
Back to top
Posted April 06, 2020.
Download PDF
Data/Code
Email
Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process
José G B Derraik, William A Anderson, Elisabeth A Connelly, Yvonne C Anderson
medRxiv 2020.04.02.20051409; doi: https://doi.org/10.1101/2020.04.02.20051409
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area